Acta Neurologica Belgica

, Volume 114, Issue 1, pp 75–76 | Cite as

Role of environmental factors in Cryptococcal meningitis in immunocompetent individuals

Letter to the Editor


  1. 1.
    Bicanic T, Harrison TS (2005) Cryptococcal meningitis. Br Med Bull 72:99–118PubMedCrossRefGoogle Scholar
  2. 2.
    Imwidthaya P, Poungvarin N (2000) Cryptococcosis in AIDS. Postgrad Med J 76(892):85–88PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Lui G, Lee N, Ip M, Choi KW, Tso YK, Lam E, Chau S, Lai R, Cockram CS (2006) Cryptococcosis in apparently immunocompetent patients. QJM 99(3):143–151PubMedCrossRefGoogle Scholar
  4. 4.
    Molesworth AM, Cuevas LE, Connor SJ, Morse AP, Thomson MC (2003) Environmental risk and meningitis epidemics in Africa. Emerg Infect Dis 9(10):1287–1293PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Larsen RA, Bauer M, Thomas AM, Graybill JR (2004) Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis. Antimicrob Agents Chemother 48(3):985–991PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Belgian Neurological Society 2013

Authors and Affiliations

  • Abdul Qayyum Rana
    • 1
  • Usman Saeed
    • 1
    • 2
  • Afshan N. Rana
    • 1
  1. 1.Parkinson’s Clinic of Eastern Toronto and Movement Disorders CenterTorontoCanada
  2. 2.Department of Biological SciencesUniversity of TorontoTorontoCanada

Personalised recommendations